[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].
The authors describe regimens of Zofran application convenient in oncological practice to prevent nausea and vomiting in patients receiving cytostatic drugs. It is well tolerated and low toxic.
Perevodchikova
N I
NI
Volkova
M A
MA
Gorbunova
V A
VA
Manziuk
L V
LV
Marenich
A F
AF
Smirnova
N B
NB
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004341:Drug Evaluation; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D017294:Ondansetron / Q000008:administration & dosage*; D012702:Serotonin Antagonists / Q000008:administration & dosage*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
D012702:Serotonin Antagonists; D017294:Ondansetron
Antagonist retseptorov 5HT3 zofran (ondansteron) kak sredstvo preduprezhdeniia toshnoty i rvoty pri tsitosticheskom lechenii onkologicheskikh bol'nykh.